UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancer

June 16, 2026 06:45 AM EDT FinancingChina Ex­clu­sive: UCSF spin­out nets $9.1M to test virus ther­a­py for brain can­cer in Chi­na Ryan Cross Senior Science Correspondent Glioblas­toma is no­to­ri­ous­ly good at evad­ing the im­mune sys­tem, mak­ing it par­tic­u­lar­ly re­sis­tant to im­munother­a­py, but now re­searchers may have found a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER